teaser
In the past 20 years concurrent chemoradiotherapy has gained popularity over induction chemotherapy (ICT). Positive trial results with docetaxel prompt the conclusion that ICT must be revisited.
This site is intended for health professionals only
teaser
In the past 20 years concurrent chemoradiotherapy has gained popularity over induction chemotherapy (ICT). Positive trial results with docetaxel prompt the conclusion that ICT must be revisited.